Maria Teresa Bejarano

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

Michael Wang, Luis Fayad, Nicolaus A. Wagner‐Bartak et al. · The Lancet Oncology · 2012 · 296 citations

Phase 1/2, Lymphoid Neoplasia, Hematological Malignancy +8

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial

M Wang, Nathan Fowler, Nicolaus A. Wagner‐Bartak et al. · Leukemia · 2013 · 203 citations

Lymphoid Neoplasia, Medicine, Malignant Blood Disorder +6

A Molecular Link between Malaria and Epstein–Barr Virus Reactivation

Arnaud Chêne, Daria Donati, André Ortlieb Guerreiro‐Cacais et al. · PLoS Pathogens · 2007 · 179 citations · Full text

Identification of a Polyclonal B-Cell Activator in<i>Plasmodium falciparum</i>

Daria Donati, Liping Zhang, Qijun Chen et al. · Infection and Immunity · 2004 · 145 citations · Full text

The epstein‐barr virus latent membrane protein‐1 (LMP1) induces interleukin‐10 production in burkitt lymphoma lines

Hiroshi Nakagomi, Riccardo Dolcetti, Maria Teresa Bejarano et al. · International Journal of Cancer · 1994 · 140 citations

Burkitt Lymphoma Lines, Immunology, Pathology +18